Structures and mechanism of the monoamine oxidase family
Open accessAbstract
Members of the monoamine oxidase family of flavoproteins catalyze the oxidation of primary and secondary amines, polyamines, amino acids, and methylated lysine side chains in proteins. The enzymes have similar overall structures, with conserved flavin adenine dinucleotide (FAD)-binding domains and varied substrate-binding sites. Multiple mechanisms have been proposed for the catalytic reactions of these enzymes. The present review compares the structures of different members of the family and the various mechanistic proposals.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LDX reduces monoamine degradation by MAO inhibition.
“The inhibition of DAT1, targeted by both drugs, leads to no reuptake of the DA to the cytosol [166]; LDX also reduces monoamine degradation by MAO inhibition [167, 168].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [167]
The “Monoamine Oxidases A and B” section (page unavailable) says MAOs metabolize dopamine and other monoamines and discusses MAO inhibitors. It does not say that LDX inhibits MAO or reduces monoamine degradation, so the drug-specific claim is unsupported. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 120 · Cited by 247
Research works printed but not linked: 104
- [1]Wierenga RK de Jong RJ Kalk KH Hol WGJ Drenth J Crystal structure of p-hydroxybenzoate hydroxylase J. Mol. Biol 1979 131 55 73 40036
- [2]Schreuder HA van der Laan JM Hol WGJ Drenth J Crystal structure of p-hydroxybenzoate hydroxylase complexed with its reaction product 3,4-dihydroxybenzoate J.Mol.Biol 1988 199 637 648 3351945
- [4]Edmondson DE Aminium cation radical mechanism proposed for monoamine oxidase B catalysis: are there alternatives? Xenobiotica 1995 25 735 753 7483670
- [6]Fitzpatrick PF Oxidation of amines by flavoproteins Arch. Biochem. Biophys 2010 493 13 25 19651103 PMC2812625
- [7]Walker MC Edmondson DE Structure-activity relationships in the oxidation of benzylamine analogues by bovine liver mitochondrial monoamine oxidase B Biochemistry 1994 33 7088 7098 8003474
- [8]Edmondson DE Bhattacharyya AK Walker MC Spectral and kinetic studies of imine product formation in the oxidation of p-(N,N-dimethylamino) benzylamine analogues by monoamine oxidase B Biochemistry 1993 32 5196 5202 8494896
- [10]Fowler CJ Benedetti MS The Metabolism of Dopamine by Both Forms of Monoamine Oxidase in the Rat Brain and Its Inhibition by Cimoxatone J. Neurochem 1983 40 1534 1541 6406646
- [11]McCauley R Racker E Separation of two monoamine oxidases from bovine bran Mol. Cell. Biochem 1973 1 73 81 4214998
- [12]Yang H-TT Neff NH β-Phenethylamine: a specific substrate for type B monoamine oxidase of brain J. Pharmacol. Exp. Ther 1973 187 365 371 4748552
- [13]Hall DWR Logan BW Parsons GH Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline)--I: Substrate specificity in various mammalian species Biochem. Pharmacol 1969 18 1447 1454 5799116
- [14]Chiba K Trevor A Castagnoli N Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase Biochem. Biophys. Res. Commun 1984 120 574 578 6428396
- [15]Cesura AM Pletscher A The new generation of monoamine oxidase inhibitors Progress in Drug Research 1992 38 171 297 1609114
- [16]Youdim MBH Edmondson D Tipton KF The therapeutic potential of monoamine oxidase inhibitors Nat. Rev. Neurosci 2006 7 295 309 16552415
- [17]Ma J Yoshimura M Yamashita E Nakagawa A Ito A Tsukihara T Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors J. Mol. Biol 2004 338 103 114 15050826
- [18]Binda C Newton-Vinson P Hubalek F Edmondson DE Mattevi A Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders Nat. Struct. Biol 2002 9 22 26 11753429
- [19]Upadhyay AK Borbat PP Wang J Freed JH Edmondson DE Determination of the Oligomeric States of Human and Rat Monoamine Oxidases in the Outer Mitochondrial Membrane and Octyl β-d-Glucopyranoside Micelles Using Pulsed Dipolar Electron Spin Resonance Spectroscopy Biochemistry 2008 47 1554 1566 18198902
- [20]De Colibus L Li M Binda C Lustig A Edmondson DE Mattevi A Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B Proc. Nat. Acad. Sci. USA 2005 102 12684 12689 16129825 PMC1200291
- [21]Rebrin I Geha RM Chen K Shih JC Effects of Carboxyl-terminal Truncations on the Activity and Solubility of Human Monoamine Oxidase B J. Biol. Chem 2001 276 29499 29506 11371556
- [22]Binda C Li M Hubalek F Restelli N Edmondson D Mattevi A Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures Proc. Natl. Acad. Sci. USA 2003 100 9750 9755 12913124 PMC187837
- [23]Nandigama RK Miller JR Edmondson D Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A Biochemistry 2001 40 14839 14846 11732903
- [24]Li M Binda C Mattevi A Edmondson DE Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins Biochemistry 2006 45 4775 4784 16605246
- [25]Geha RM Chen K Wouters J Ooms F Shih JC Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling J. Biol. Chem 2002 277 17209 17216 11861643 PMC2844881
- [28]Edmondson DE Binda C Mattevi A Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B Arch. Biochem. Biophys 2007 464 269 276 17573034 PMC1993809
- [29]Hubálek F Binda C Khalil A Li M Mattevi A Castagnoli N Edmondson DE Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors J. Biol. Chem 2005 280 15761 15766 15710600
- [30]Son S-Y Ma J Kondou Y Yoshimura M Yamashita E Tsukihara T Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors Proc. Nat. Acad. Sci. USA 2008 105 5739 5744 18391214 PMC2311356
- [31]Miller JR Edmondson DE Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A Biochemistry 1999 38 13670 13683 10521274
- [32]Dunn RV Marshall KR Munro AW Scrutton NS The pH dependence of kinetic isotope effects in monoamine oxidase A indicates stabilization of the neutral amine in the enzyme-substrate complex FEBS Journal 2008 275 3850 3858 18573102
- [33]Nandigama RK Edmondson DE Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A Biochemistry 2000 39 15258 15265 11106506
- [34]Pretorius A Ogunrombi MO Terre'Blanche G Castagnoli N Jr Bergh JJ Petzer JP Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B Biorg. Med. Chem 2008 16 8813 8817 18799315
- [35]Silverman RB Effect of α-methylation on inactivation of monoamine oxidase by N-cyclopropylbenzylamine Biochemistry 1984 23 5206 5213 6509020
- [36]Silverman RB Zieske PA Mechanism of inactivation of monoamine oxidase by 1-phenylcyclopropylamine Biochemistry 1985 24 2128 2138 3995007
- [38]Yue KT Bhattacharyya AK Zhelyaskov VR Edmondson DE Resonance Raman Spectroscopic Evidence for an Anionic Flavin Semiquinone in Bovine Liver Monoamine Oxidase Arch. Biochem. Biophys 1993 300 178 185 8424650
- [39]DeRose VJ Woo JCG Hawe WP Hoffman BM Silverman RB Yelekci K Observation of a flavin semiquinone in the resting state of monoamine oxidase B by electron paramagnetic resonance and electron nuclear double resonance spectroscopy Biochemistry 1996 35 11085 11091 8780511
- [40]Sablin SO Ramsay RR Substrates but not inhibitors alter the redox potentials of monoamine oxidases Antioxid. Redox Signal 2001 3 723 729 11761322
- [41]Rigby SE Hynson RM Ramsay RR Munro AW Scrutton NS A stable tyrosyl radical in monoamine oxidase A J. Biol. Chem 2005 280 4627 4631 15556933
- [42]Royo M Fitzpatrick PF Mechanistic studies of mouse polyamine oxidase with N1,N12-bisethylspermine as a substrate Biochemistry 2005 44 7079 7084 15865452 PMC1635011
- [46]Massey V Activation of molecular oxygen by flavins and flavoproteins J.Biol.Chem 1994 269 22459 22462 8077188
- [47]Roth JP Klinman JP Catalysis of electron transfer during the activation of O2 by the flavoprotein glucose oxidase Proc. Natl. Acad. Sci. USA 2003 100 62 67 12506204 PMC404145
- [48]Jorns MS Chen Z-w Mathews FS Structural Characterization of Mutations at the Oxygen Activation Site in Monomeric Sarcosine Oxidase Biochemistry 2010 PMC2912214 20353187
- [49]Zhao G Bruckner RC Jorns MS Identification of the Oxygen Activation Site in Monomeric Sarcosine Oxidase: Role of Lys265 in Catalysis Biochemistry 2008 47 9124 9135 18693755 PMC2764408
- [50]Tabor CW Tabor H Polyamines Ann. Rev. Biochem 1984 53 749 790 6206782
- [51]Hu RH Pegg AE Rapid induction of apoptosis by deregulated uptake of polyamine analogues Biochem. J 1997 328 307 316 9359869 PMC1218922
- [52]Casero RA Woster PM Recent Advances in the Development of Polyamine Analogues as Antitumor Agents J. Med. Chem 2009 52 4551 4573 19534534 PMC2762202
- [54]Marton LJ Pegg AE Polyamines as targets for therapeutic intervention Ann.Rev.Pharmacol.Toxicol 1995 35 55 91 7598507
- [55]Holtta E Oxidation of spermidine and spermine in rat liver: purification and properties of polyamine oxidase Biochemistry 1977 16 91 100 12798
- [56]Wu T Yankovskaya V McIntire WS Cloning, sequencing, and heterologous expression of the murine peroxisomal flavoprotein, N1-acetylated polyamine oxidase J. Biol. Chem 2003 278 20514 20525 12660232
- [58]Kim BG Polyamine metabolism in Acanthamoeba: polyamine content and synthesis of ornithine, putrescine, and diaminopropane J. Protozoology 1987 34 728 784 3656216
- [59]Wang Y Murray-Stewart T Devereux W Hacker A Frydman B Woster PM Casero RA Jr Properties of purified recombinant human polyamine oxidase, PAOh1/SMO Biochem. Biophys. Res. Commun 2003 304 605 611 12727196
- [60]Cervelli M Polticelli F Federico R Mariottini P Heterologous expression and characterization of mouse spermine oxidase J. Biol. Chem 2003 278 5271 5276 12458219
- [61]Wang Y Devereux W Woster PM Stewart TM Hacker A Casero RA Jr Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure Cancer Res 2001 61 5370 5373 11454677
- [62]Pledgie A Huang Y Hacker A Zhang Z Woster PM Davidson NE Casero RA Jr Spermine oxidase SMO(PAOh1), not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines J. Biol. Chem 2005 280 39843 39851 16207710
- [63]Ha HC Woster PM Yager JD Casero RA Jr The role of polyamine catabolism in polyamine analogue-induced programmed cell death Proc. Natl. Acad. Sci. U S A 1997 94 11557 11562 9326648 PMC23536
- [64]Babbar N Casero RA Jr Tumor Necrosis Factor-α Increases Reactive Oxygen Species by Inducing Spermine Oxidase in Human Lung Epithelial Cells: A Potential Mechanism for Inflammation-Induced Carcinogenesis Cancer Res 2006 66 11125 11130 17145855
- [65]Tavladoraki P Schininá ME Cecconi F Di Agostino S Manera F Rea G Mariottini P Federico R Angelini R Maize polyamine oxidase: primary structure from protein and cDNA sequencing FEBS Lett 1998 426 62 66 9598979
- [66]Binda C Coda A Angelini R Federico R Ascenzi P Mattevi A A 30 Å long U-shaped catalytic tunnel in the crystal structure of polyamine oxidase Structure 1999 7 265 276 10368296
- [67]Binda C Angelini R Federico R Ascenzi P Mattevi A Structural bases for inhibitor binding and catalysis in polyamine oxidase Biochemistry 2001 40 2766 2776 11258887
- [68]Landry J Sternglanz R Yeast Fms1 is a FAD-utilizing polyamine oxidase Biochem. Biophys. Res. Commun 2003 303 771 776 12670477
- [69]Huang Q Liu Q Hao Q Crystal structures of Fms1 and its complex with spermine reveal substrate specificity J. Mol. Biol 2005 348 951 959 15843025
- [70]Bianchi M Polticelli F Ascenzi P Botta M Federico R Mariottini P Cona A Inhibition of polyamine and spermine oxidases by polyamine analogues FEBS. J 2006 273 1115 1123 16519678
- [71]Adachi MS Torres JM Fitzpatrick PF Mechanistic Studies of the Yeast Polyamine Oxidase Fms1: Kinetic Mechanism, Substrate Specificity, and pH Dependence Biochemistry 2010 49 10440 10448 21067138 PMC2999662
- [72]Adachi MS Juarez PR Fitzpatrick PF Mechanistic Studies of Human Spermine Oxidase: Kinetic Mechanism and pH Effects Biochemistry 2010 49 386 392 20000632 PMC2810717
- [73]Henderson Pozzi M Gawandi V Fitzpatrick PF pH Dependence of a Mammalian Polyamine Oxidase: Insights into Substrate Specificity and the Role of Lysine 315 Biochemistry 2009 48 1508 1516 19199575 PMC2752350
- [74]Henderson Pozzi M Gawandi V Fitzpatrick PF Mechanistic Studies of para-Substituted N,N,-Dibenzyl-1,4-diaminobutanes as Substrates for a Mammalian Polyamine Oxidase Biochemistry 2009 48 12305 12313 19911805 PMC2797579
- [75]Polticelli F Basran J Faso C Cona A Minervini G Angelini R Federico R Scrutton NS Tavladoraki P Lys300 plays a major role in the catalytic mechanism of maize polyamine oxidase Biochemistry 2005 44 16108 16120 16331971
- [76]Henderson Pozzi M Fitzpatrick PF A lysine conserved in the monoamine oxidase family is involved in oxidation of the reduced flavin in mouse polyamine oxidase Arch. Biochem. Biophys 2010 498 83 88 20417173 PMC2880204
- [77]Pawelek PD Cheah J Coulombe R Macheroux P Ghisla S Vrielink A The structure of L-amino acid oxidase reveals the substrate trajectory into an enantiomerically conserved active site EMBO J 2000 19 4204 4215 10944103 PMC302035
- [78]Moustafa IM Foster S Lyubimov AY Vrielink A Crystal structure of LAAO from Calloselasma rhodostoma with an L-phenylalanine substrate: insights into structure and mechanism J. Mol. Biol 2006 364 991 1002 17046020 PMC2018609
- [79]Faust A Niefind K Hummel W Schomburg D The structure of a bacterial L-amino acid oxidase from Rhodococcus opacus gives new evidence for the hydride mechanism for dehydrogenation J. Mol. Biol 2007 367 234 248 17234209
- [80]Curti B Ronchi S Simonetta MP Müller F D- and L-amino acid oxidases Chemistry and Biochemistry of Flavoenzymes 1991 Vol III Boca Raton CRC Press 69 94
- [81]Fitzpatrick PF Substrate dehydrogenation by flavoproteins Acc. Chem. Res 2001 34 299 307 11308304
- [82]Fitzpatrick PF Carbanion versus hydride transfer mechanisms in flavoprotein-catalyzed dehydrogenations Bioorg. Chem 2004 32 125 139 15110192
- [83]Magie AR Wilson EE Kosuge T Indoleacetamide as an intermediate in the synthesis of indoleacetic acid in Pseudomonas savastanoi Science 1963 141 1281 1282 14059783
- [84]Thomashow MF Hugly S Buchholz WG Thomashow LS Molecular basis for the auxin-independent phenotype of crown gall tumor tissues Science 1986 231 616 618 3511528
- [85]Sobrado P Fitzpatrick PF Analysis of the roles of amino acid residues in the flavoprotein tryptophan 2-monooxygenase modified by 2-oxo-3-pentynoate: characterization of His338, Cys339, and Cys511 mutant enzymes Arch.Biochem.Biophys 2002 402 24 30 12051679
- [86]Sobrado P Fitzpatrick P Analysis of the role of the active site residue Arg98 in the flavoprotein tryptophan 2-monooxygenase, a member of the L-amino oxidase family Biochemistry 2003 42 13826 13832 14636049 PMC1635017
- [87]Sobrado P Fitzpatrick PF Identification of Tyr413 as an active site residue in the flavoprotein tryptophan 2-monooxygenase and analysis of its contribution to catalysis Biochemistry 2003 42 13833 13838 14636050 PMC1630680
- [88]Emanuele JJ Jr Fitzpatrick PF Mechanistic studies of the flavoprotein tryptophan 2-monooxygenase. 1. Kinetic mechanism Biochemistry 1995 34 3710 3715 7893667
- [89]Emanuele JJ Jr Fitzpatrick PF Mechanistic studies of the flavoprotein tryptophan 2-monooxygenase. 2. pH and kinetic isotope effects Biochemistry 1995 34 3716 3723 7893668
- [90]Ralph EC Anderson MA Cleland WW Fitzpatrick PF Mechanistic studies of the flavoenzyme tryptophan 2-monooxygenase: Deuterium and 15N kinetic isotope effects on alanine oxidation by an L-amino acid oxidase Biochemistry 2006 45 15844 15852 17176107 PMC1994567
- [91]Ralph EC Hirschi JS Anderson MA Cleland WW Singleton DA Fitzpatrick PF Insights into the mechanism of flavoprotein-catalyzed amine oxidation from nitrogen isotope effects on the reaction of N-methyltryptophan oxidase Biochemistry 2007 46 7655 7664 17542620 PMC2041825
- [92]Shi Y Lan F Matson C Mulligan P Whetstine JR Cole PA Casero RA Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 2004 119 941 953 15620353
- [93]Forneris F Binda C Vanoni MA Mattevi A Battaglioli E Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process FEBS Lett 2005 579 2203 2207 15811342
- [94]Huang J Sengupta R Espejo AB Lee MG Dorsey JA Richter M Opravil S Shiekhattar R Bedford MT Jenuwein T Berger SL p53 is regulated by the lysine demethylase LSD1 Nature 2007 449 105 108 17805299
- [95]Zhu X Wang J Ju BG Rosenfeld MG Signaling and epigenetic regulation of pituitary development Curr. Opin. Cell Biol 2007 19 605 611 17988851 PMC2796608
- [96]Su ST Ying HY Chiu YK Lin FR Chen MY Lin KI Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation Mol. Cell Biol 2009 29 1421 1431 19124609 PMC2648243
- [97]Saleque S Kim J Rooke HM Orkin SH Epigenetic Regulation of Hematopoietic Differentiation by Gfi-1 and Gfi-1b Is Mediated by the Cofactors CoREST and LSD1 Mol. Cell 2007 27 562 572 17707228
- [98]Hakimi M-A Bochar DA Chenoweth J Lane WS Mandel G Shiekhattar R A core–BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes Proc. Natl. Acad. Sci. U S A 2002 99 7420 7425 12032298 PMC124246
- [99]Schulte JH Lim S Schramm A Friedrichs N Koster J Versteeg R Ora I Pajtler K Klein-Hitpass L Kuhfittig-Kulle S Metzger E Schule R Eggert A Buettner R Kirfel J Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy Cancer Res 2009 69 2065 2071 19223552
- [100]Kahl P Gullotti L Heukamp LC Wolf S Friedrichs N Vorreuther R Solleder G Bastian PJ Ellinger J Metzger E Schule R Buettner R Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence Cancer Res 2006 66 11341 11347 17145880
- [101]Culhane JC Szewczuk LM Liu X Da G Marmorstein R Cole PA A mechanism-based inactivator for histone demethylase LSD1 J. Am. Chem. Soc 2006 128 4536 4537 16594666
- [102]Szewczuk LM Culhane JC Yang M Majumdar A Yu H Cole PA Mechanistic analysis of a suicide inactivator of histone demethylase LSD1 Biochemistry 2007 46 6892 6902 17511474 PMC2531293
- [103]Yang M Culhane JC Szewczuk LM Jalili P Ball HL Machius M Cole PA Yu H Structural Basis for the Inhibition of the LSD1 Histone Demethylase by the Antidepressant trans-2-Phenylcyclopropylamine Biochemistry 2007 46 8058 8065 17569509
- [104]Gooden DM Schmidt DMZ Pollock JA Kabadi AM McCafferty DG Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B Bioorg. Med. Chem. Lett 2008 18 3047 3051 18242989 PMC2661354
- [105]Schmidt DMZ McCafferty DG trans-2-Phenylcyclopropylamine Is a Mechanism-Based Inactivator of the Histone Demethylase LSD1 Biochemistry 2007 46 4408 4416 17367163
- [106]Lee MG Wynder C Schmidt DM McCafferty DG Shiekhattar R Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications Chem. Biol 2006 13 563 567 16793513
- [107]Forneris F Binda C Adamo A Battaglioli E Mattevi A Structural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition J. Biol. Chem 2007 282 20070 20074 17537733
- [108]Chen Y Yang Y Wang F Wan K Yamane K Zhang Y Lei M Crystal structure of human histone lysine-specific demethylase 1 (LSD1) Proc. Natl. Acad. Sci. USA 2006 103 13956 13961 16956976 PMC1599895
- [109]Da G Lenkart J Zhao K Shiekhattar R Cairns BR Marmorstein R Structure and function of the SWIRM domain, a conserved protein module found in chromatin regulatory complexes Proc. Natl. Acad. Sci. U S A 2006 103 PMC1413740 16461455
- [110]Stavropoulos P Blobel G Hoelz A Crystal structure and mechanism of human lysine-specific demethylase-1 Nat. Struct. Mol. Biol 2006 13 626 632 16799558
- [111]Metzger E Wissmann M Yin N Muller JM Schneider R Peters AHFM Gunther T Buettner R Schule R LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature 2005 437 436 439 16079795
- [112]Mimasu S Sengoku T Fukuzawa S Umehara T Yokoyama S Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å Biochem. Biophys. Res. Commun 2008 366 15 22 18039463
- [113]Forneris F Battaglioli E Mattevi A Binda C New roles of flavoproteins in molecular cell biology: Histone demethylase LSD1 and chromatin FEBS Journal 2009 276 4304 4312 19624733
- [114]Gaweska H Henderson Pozzi M Schmidt DMZ McCafferty DG Fitzpatrick PF Use of pH and Kinetic Isotope Effects to Establish Chemistry As Rate-Limiting in Oxidation of a Peptide Substrate by LSD1 Biochemistry 2009 48 5440 5445 19408960 PMC2738601
- [115]Pettersen EF Goddard TD Huang CC Couch GS Greenblatt DM Meng EC Ferrin TE UCSF Chimera—A visualization system for exploratory research and analysis J. Comput. Chem 2004 25 1605 1612 15264254
- Authors
- Gaweska, H., & Fitzpatrick, P. F.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Fitzpatrick, Paul F.
- ORCID
- Fitzpatrick, Paul F.
- Venue
- bmc
- Publisher
- Walter de Gruyter GmbH
- Published
- 2011-08-13
- Volume
- 2
- Issue
- 5
- Pages
- 365-377
- ISSN
- 1868-5021 (ISSN-L)
- 1868-503X
- PMC
- PMC3197729
- OpenAlex
- W2058494541
- Cited by
- 247
- References
- 120
- Citations by year
- 2026: 25 · 2025: 21 · 2024: 26 · 2023: 35 · 2022: 22 · 2021: 29 · 2020: 25 · 2019: 20 · 2018: 10 · 2017: 7 · 2016: 9 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 1
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BioMolecular Concepts (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of General Medical Sciences (F32GM097762, R01GM058698)
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- monoamine oxidase, flavoprotein, FAD-binding domain, enzyme structure, catalytic mechanism, polyamine oxidation, amino acid oxidation, substrate binding site
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review